Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
Condition(s):Tourette SyndromeLast Updated:January 30, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Tourette SyndromeLast Updated:January 30, 2018Completed
Condition(s):Cocaine Use DisordersLast Updated:July 6, 2018Completed
Condition(s):Hepatic EncephalopathyLast Updated:January 3, 2024Recruiting
Condition(s):CirrhosisLast Updated:March 12, 2024Recruiting
Condition(s):Liver Dysfunction; Sepsis-associated Liver DysfunctionLast Updated:August 21, 2023Recruiting
Condition(s):Liver Failure, AcuteLast Updated:March 21, 2023Not yet recruiting
Condition(s):PeriodontitisLast Updated:September 17, 2021Completed
Condition(s):Pain, PostoperativeLast Updated:January 18, 2020Terminated
Condition(s):Multiple SclerosisLast Updated:September 2, 2020Completed
Condition(s):Cocaine Use DisordersLast Updated:February 5, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.